Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Children (Basel) ; 9(11)2022 Nov 17.
Article in English | MEDLINE | ID: mdl-36421216

ABSTRACT

BACKGROUND: We evaluated the efficacy of Cord Blood Platelet Gel (CBPG) in the regenerative reconstruction of the nasal septal tissue of a preterm infant undergoing non-invasive ventilation. METHODS: A CBPC treatment was used to enhance the regeneration of the nasal septum of a premature patient in an experimental way, evaluating the efficacy described in the literature (selective bibliographic search in PubMed) of the use of blood products for non-transfusion purposes. RESULTS: A partial but satisfactory regeneration of the patient's nasal septum was observed. Using the free NIH Image J online software, we were able to calculate the regenerated surface (about 83% of the destroyed cartilage). CONCLUSIONS: The use of platelet gel has been a promising alternative to surgical treatment in patients with severe damage to the nasal septum.

2.
Epileptic Disord ; 24(1): 140-150, 2022 Feb 01.
Article in English | MEDLINE | ID: mdl-34821559

ABSTRACT

OBJECTIVE: To assess the potential risk of developing epilepsy in preterm newborns with neonatal seizures (NS). Two electronic databases (PubMed and Web of Sciences) were searched from inception to December 2020. Studies that investigated the outcome of epilepsy in neonates with NS were included. METHODS: Case-control, cross-sectional and cohort studies were included. Data synthesis was undertaken via systematic review and meta-analysis of available evidence. All review stages were conducted by three independent reviewers. We analysed data on neonates with NS who developed post-neonatal epilepsy (PNE) based on the data reported in the selected articles. We then investigated the development of PNE in term and preterm neonates. RESULTS: The initial search led to 568 citations, of which 12 were selected for the review and six were eligible for meta-analysis. Results of the meta-analysis showed no significant difference in the risk of developing PNE between full-term infants with NS (pooled OR [pOR]=0.92: 95% CI: 0.58-1.44) and preterm neonates. SIGNIFICANCE: Gestational age does not seem to be an independent predictor for the development of PNE in neonates with NS. More data are needed to explore the relationship between seizures in the neonatal period and epilepsy later in life.


Subject(s)
Epilepsy , Infant, Newborn, Diseases , Seizures , Cross-Sectional Studies , Epilepsy/epidemiology , Humans , Infant, Newborn , Infant, Newborn, Diseases/epidemiology , Infant, Premature , Seizures/epidemiology
3.
Sci Rep ; 11(1): 20235, 2021 10 12.
Article in English | MEDLINE | ID: mdl-34642378

ABSTRACT

In these last 25 years, the Neonatal Emergency Transport (NET) service has been widely improved in Italy. To date, all National areas are covered by a NET service; 53 NET centers have been activated in all the Italian territory. Herein, the authors present an observational study to evaluate the rate of infantile mortality after introduction of NET in Sicily, and to study the efficiency of this service in reducing these rates of mortality in vulnerable neonates, transported from primary care birth centers to tertiary facilities to undergo to specialized NICU assistance. All neonates who required an emergency transport by NETS were included. No exclusions criteria were applied. Demographic and regional infantile mortality data, expressed as infant mortality rate, were selected by the official government database (ISTAT- National Statistic Institute- http://www.istat.it ). All data were respectively divided into three groups: data concerning transport, clinical condition, and mortality of the transported patients. We transported by NET 325 neonates. The analysis of the infant mortality rate (per 1.000 live births) in Catania from 2016 to 2018 was reduced compared to the same rate calculated before NETS activation (4.41 index before 2016 vs 4.17 index after 2016). These data showed an increase in other provinces (Enna, Caltanissetta, and Agrigento). 61% of neonates showed a respiratory disease. During the study period the proportion of neonates with a Mortality Index for Neonatal Transportation-MINT < 6 has been reduced, while there was an increase of neonates with higher Transport Risk Index of Physiologic Stability-TRIPS score results. The slight decrease of infantile mortality in Catania during the first three years after introduction of NET follows the same trend of all Italian territories, showing the importance of this service in reducing infantile mortality.


Subject(s)
Infant Mortality/trends , Intensive Care, Neonatal/methods , Respiratory Tract Diseases/epidemiology , Transportation of Patients/methods , Female , Humans , Infant , Infant, Newborn , Male , Respiratory Tract Diseases/mortality , Retrospective Studies , Sicily/epidemiology , Tertiary Care Centers
4.
Crit Care Res Pract ; 2021: 1782406, 2021.
Article in English | MEDLINE | ID: mdl-34426771

ABSTRACT

BACKGROUND: Neonatal brain injury (NBI) can lead to a significant neurological disability or even death. After decades of intense efforts to improve neonatal intensive care and survival of critically ill newborns, the focus today is an improved long-term neurological outcome through brain-focused care. The goal of neuroprotection in the neonatal intensive care unit (NICU) is the prevention of new or worsening NBI in premature and term newborns. As a result, the neonatal neurocritical care unit (NNCU) has been emerging as a model of care to decrease NBI and improve the long-term neurodevelopment in critically ill neonates. PURPOSE: Neurocritical care (NCC) Sicilian project includes three academic sites with NICU in Sicily (Catania, Messina, and Palermo), and its primary goal is to develop neurocritical neonatal care unit (NNCU). METHODS: In 2018, the three NICUs created a dedicated space for neonates with primary neurological diagnosis or at risk for neurological injuries-NNCU. Admission criteria for eligible patients and treatment protocols were created. Contact with parents, environmental protection, basic monitoring, brain monitoring, pharmacological therapy, and organization of the staff were protocolized. RESULTS: Evaluation of the efforts to establish NNCU within existing NICU, current protocols, and encountered problems are shown. Implications for Practice. Our outcome confirmed the need for dedicated NNCU for neuroprotection of critically ill neonates at risk for a neurological injury. Although the literature on neonatal neurocritical care is still scarce, we see the value of such targeted approach to newborn brain protection and therefore we will continue developing our NNCU, even though there have been problems encountered. The project of building NNCU will continue to be closely monitored. CONCLUSIONS: The development of our neonatal neurocritical model of care is far from being completed. Although it is currently limited to the Sicilian area only, the goal of this paper is to share the development of this multicenter interdisciplinary project focused on a newborn brain protection. After evaluating our outcome, we strongly believe that a combined expertise in neonatal neurology and neonatal critical care can lead to an improved neurodevelopmental outcome for critically ill neonates, from the extremely preterm to those with brain injuries.

5.
J Clin Med ; 10(9)2021 Apr 30.
Article in English | MEDLINE | ID: mdl-33946596

ABSTRACT

BACKGROUND: The association between inflammatory bowel disease (IBD) and immune thrombocytopenia (ITP) is still uncertain. In this multicenter retrospective study, the coexistence of both diseases was investigated in children diagnosed from 1 January 2000 to 31 December 2019. METHODS: Clinical characteristics of both IBD and ITP, onset of disorders, and patient's response to treatment were collected through a structured form sent to 55 Italian pediatric referring centers for hematological disorders. RESULT: Centers responded to the survey and reported the coexistence of IBD and ITP in 14 children. The first diagnosis was ITP in 57.1% and IBD in 35.7% of patients: it was simultaneous in 7.1%. IBD was classified as ulcerative colitis (57.1%), Crohn disease (35.7%), and unclassified (7.1%). No therapy for IBD other than steroids had any effect on ITP course. Colectomy resulted in recovery from ITP in 1 of the 2 patients surgically treated. ITP was always mild but turned to be chronic in half of patients. CONCLUSIONS: In all patients, ITP was mild without any evident impact on IBD severity, but the incidence of chronic ITP seems to be higher than what is usually observed in the pediatric age group. Colectomy had unpredictable effects on ITP.

6.
Turk J Haematol ; 38(3): 175-180, 2021 08 25.
Article in English | MEDLINE | ID: mdl-34002598

ABSTRACT

Objective: The association between celiac disease (CD) and immune thrombocytopenia (ITP) is still uncertain. The aim of this study was to characterize the coexistence of these two diseases in Italian children. Materials and Methods: This is a retrospective multicenter study investigating the occurrence of CD in 28 children with ITP diagnosed from January 1, 2000, to December 31, 2019. Results: The first diagnosis was ITP in 57.1% and CD in 32.1% of patients. In 3 patients (10.7%), the two diagnoses were simultaneous. All the potential and silent cases of CD in our cohort were diagnosed in the groups of "ITP first" and "simultaneous diagnosis". In all children ITP was mild, and in 2 out of 8 not recovered from ITP at the time of CD diagnosis a normalization of platelet counts (>100,000/µL) occurred 3 and 5 months after starting a gluten-free diet, respectively. Conclusion: We think that screening for CD should be considered in children with ITP regardless of the presence of gastrointestinal symptoms. Furthermore, some patients may recover from ITP after starting a gluten-free diet.


Subject(s)
Celiac Disease , Purpura, Thrombocytopenic, Idiopathic , Thrombocytopenia , Child , Humans , Case-Control Studies , Celiac Disease/complications , Celiac Disease/diagnosis , Celiac Disease/epidemiology , Purpura, Thrombocytopenic, Idiopathic/complications , Purpura, Thrombocytopenic, Idiopathic/diagnosis , Purpura, Thrombocytopenic, Idiopathic/epidemiology , Retrospective Studies
7.
Ital J Pediatr ; 47(1): 85, 2021 Apr 07.
Article in English | MEDLINE | ID: mdl-33827647

ABSTRACT

AIM: The existing treatment options for neonatal seizures have expanded over the last few decades, but no consensus has been reached regarding the optimal therapeutic protocols. We systematically reviewed the available literature examining neonatal seizure treatments to clarify which drugs are the most effective for the treatment of specific neurologic disorders in newborns. METHOD: We reviewed all available, published, literature, identified using PubMed (published between August 1949 and November 2020), that focused on the pharmacological treatment of electroencephalogram (EEG)-confirmed neonatal seizures. RESULTS: Our search identified 427 articles, of which 67 were included in this review. Current knowledge allowed us to highlight the good clinical and electrographic responses of genetic early-onset epilepsies to sodium channel blockers and the overall good response to levetiracetam, whose administration has also been demonstrated to be safe in both full-term and preterm newborns. INTERPRETATION: Our work contributes by confirming the limited availability of evidence that can be used to guide the use of anticonvulsants to treat newborns in clinical practice and examining the efficacy and potentially harmful side effects of currently available drugs when used to treat the developing newborn brain; therefore, our work might also serve as a clinical reference for future studies.


Subject(s)
Anticonvulsants/therapeutic use , Seizures/drug therapy , Channelopathies/complications , Channelopathies/genetics , Humans , Hypoxia-Ischemia, Brain/complications , Infant, Newborn , Sodium Potassium Chloride Symporter Inhibitors/therapeutic use , Stroke/complications
8.
Am J Hematol ; 94(2): 216-222, 2019 02.
Article in English | MEDLINE | ID: mdl-30456824

ABSTRACT

Autoimmune neutropenia of infancy (AIN) is characterized by low risk of severe infection, tendency to spontaneously resolve and typically onset at ≤4-5 years of age; it is due to auto-antibodies whose detection is often difficult. In case of negativity of 4 antineutrophils autoantibody tests, after having excluded ethnic, postinfection, drug induced, or congenital neutropenia, according to the Italian guidelines the patients will be defined as affected by "idiopathic neutropenia" (IN). We describe the characteristics of 85 IN patients enrolled in the Italian neutropenia registry: they were compared with 336 children affected by AIN. The 2 groups were clinically very similar and the main differences were detection age (later in IN), length of disease (longer in IN) and, among recovered patients, age of spontaneous recovery: the median age at resolution was 2.13 years in AINs and 3.03 years in INs (P = .00002). At bivariate analysis among AIN patients earlier detection age (P = .00013), male sex (P = .000748), absence of leucopenia (P = .0045), and absence of monocytosis (P = .0419) were significantly associated with earlier recovery; in the IN group only detection age (P = .013) and absence of monocytosis (P = .0333) were significant. At multivariate analysis detection age and absence of monocytosis were independently significant (P = 6.7e-05 and 4.4e-03, respectively) in the AIN group, whereas in the IN group only detection age stayed significant (P = .013).


Subject(s)
Neutropenia/congenital , Age Factors , Autoimmunity , Congenital Bone Marrow Failure Syndromes , Diagnosis, Differential , Female , Humans , Infant , Italy , Leukopenia , Male , Neutropenia/diagnosis , Neutropenia/epidemiology , Registries , Risk Factors , Sex Factors
9.
Acta sci., Health sci ; 36(1): 1-4, jan.-jun. 2014. tab
Article in English | LILACS | ID: biblio-833415

ABSTRACT

Knowledge of specific hematological parameters of laboratory animals used in experiments is highly relevant to evaluate functional alterations of their vital organs. Hematological reference rates for rats, mice, rabbits and hamsters, bred in conventional healthy conditions and derived from the Vivarium of the FMUSP's Vivarium Center are established. One hundred and twenty mice of the strains BALB/c, C57BL / 6 and Swiss, 80 Wistar rats, 80 Golden hamsters and 80 New Zealand rabbits, males and females, apparently normal and healthy, over 10-weeks-old, were employed in current experiment. The analysis was determined by flow cytometry process (CELM CC510) involving the separation of erythrocytes and leukocytes, and cell identification by the suspension method and quantification. Hematological derivatives such as hematometric indexes (application of equations) and morphological quantification of leukocytes and erythrocytes were determined by scanning/differential (Panótico-commercial), whereas hemoglobin dosage was determined by spectrophotometry (CELM E210D). Results are given as means and standard deviants of hematological profiles in the blood of the animals grouped by species, strain and sex. Data are an important asset for researchers in their analysis of experimental results. CEAU Certificate n.° 251/11 HCFMUSP.


Conhecer os parâmetros hematológicos individuais de animais de laboratório utilizados na experimentação é importante para avaliar as alterações funcionais dos seus órgãos vitais. Este trabalho estabelece valores de referência hematológicos de roedores e lagomorfos criados em condições sanitárias convencionais, provenientes do Biotério do Centro de Bioterismo da FMUSP. Foram utilizados 120 camundongos das linhagens BALB/c, C57BL/6 e Swiss, 80 ratos Wistar, 80 hamster Golden e 80 coelhos New Zealand, machos e fêmeas, aparentemente normais e saudáveis, todos acima de 10 semanas. A análise foi determinada pelo processo de citometria de fluxo (CELM CC510) para a separação de eritrócitos e leucócitos, e a identificação celular pelo método em suspensão e quantificação. Os derivados hematológicos como índices hematimétricos (aplicação de equações), a quantificação morfológica dos leucócitos e eritrócitos foram determinados por varredura/diferencial (Panótico-comercial) e a dosagem de hemoglobina por espectrofotometria (Celm E210D). Os resultados estão apresentados pelas médias e pelos erros padrões dos perfis hematológicos encontrados no sangue dos animais, os quais estão agrupados por espécie, linhagem e sexo. Os perfis servirão como valiosa ferramenta aos pesquisadores na análise de seus resultados experimentais. Certificado CEAU n° 251/11 HCFMUSP.


Subject(s)
Mice , Blood , Sanitary Profiles , Hematologic Tests , Animals, Laboratory
10.
Maturitas ; 51(4): 370-9, 2005 Aug 16.
Article in English | MEDLINE | ID: mdl-16039410

ABSTRACT

OBJECTIVE: The purpose of this study was to evaluate the effects of two sex hormones on normal mammary gland of female rats. METHODS: Forty 250-day-old female rats, 20 of them with offspring and 20 not, were ovariectomized and, divided into 4 subgroups in order to receive one of the following subcutaneous treatment: estradiol benzoate (EB), medroxyprogesterone (MPA), EB+MPA or placebo, for 10 weeks. After treatment, mammary glands were studied with optical microscope. Whole gland, lobule, ductule and lumen compartments were evaluated by morphometric methods. Also a qualitative evaluation were performed seeking for secretion, microcalcification and trophic status. RESULTS: It was found that (a) MPA-only and placebo were similar for all parameters; (b) the same between EB and EB+MPA; (c) EB and EB+MPA increased lobule, ductule and lumen compartments significantly compared to MPA-only or placebo; (d) EB increased epithelium but without significance and EB+MPA increased it significantly compared to placebo or MPA; (e) EB and EB+MPA incremented secretion. CONCLUSIONS: In normal mammary gland of female rats: progestin action depends on estrogen presence. MPA does not revert estrogen-dependent proliferation, but it magnifies estradiol effect. Both EB and EB+MPA stimulate differentiation. Rats without offspring presented a greater epithelial proliferation under treatment with these sex hormones.


Subject(s)
Estradiol/analogs & derivatives , Mammary Glands, Animal/drug effects , Medroxyprogesterone/pharmacology , Animals , Case-Control Studies , Cell Proliferation/drug effects , Estradiol/administration & dosage , Estradiol/pharmacology , Female , Linear Models , Mammary Glands, Animal/pathology , Medroxyprogesterone/administration & dosage , Random Allocation , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...